Kerdiles O, Oye Mintsa Mi-Mba MF, Coulombe K, Tremblay C, Émond V, Saint-Pierre M, Rouxel C, Berthiaume L, Julien P, Cicchetti F, Calon F

Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease

Neural Regen Res, 20 (2), 2025.

Résumé | Liens:

Barolet AB, Magne B, Barolet D, Germain L

Differential Nitric Oxide Responses in Primary Cultured Keratinocytes and Fibroblasts to Visible and Near-Infrared Light

Antioxidants (Basel), 13 (10), 2024.

| Liens:

Perofsky AC, Huddleston J, Hansen CL, Barnes JR, Rowe T, Xu X, Kondor R, Wentworth DE, Lewis N, Whittaker L, Ermetal B, Harvey R, Galiano M, Daniels RS, McCauley JW, Fujisaki S, Nakamura K, Kishida N, Watanabe S, Hasegawa H, Sullivan SG, Barr IG, Subbarao K, Krammer F, Bedford T, Viboud C

Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States

Elife, 13 , 2024.

Résumé | Liens:

Bourque M, Morissette M, Isenbrandt A, Giatti S, Cosimo Melcangi R, Carta M, Frau R, Bortolato M, Soulet D, Di Paolo T

Effect of 5-alpha reductase inhibitors in animal models of Parkinson's disease

Front Neuroendocrinol, 2024.

Résumé | Liens:

O'Hearn K, Menon K, Albrecht L, Amrein K, Britz-McKibbin P, Cayouette F, Choong K, Foster JR, Fergusson DA, Floh A, Fontela P, Geier P, Gilfoyle E, Guerra GG, Gunz A, Helmeczi E, Khamessan A, Joffe AR, Lee L, McIntyre L, Murthy S, Parsons SJ, Ramsay T, Ryerson L, Tucci M, McNally D,

Rapid normalization of vitamin D deficiency in PICU (VITdALIZE-KIDS): study protocol for a phase III, multicenter randomized controlled trial

Trials, 25 (1), 2024.

Résumé | Liens: